Ping An Biomedical (PASW) Cash & Equivalents (2024 - 2025)
Ping An Biomedical (PASW) reported Cash & Equivalents of $163816.4 for Q3 2025, up 796.76% on a YoY basis from $18267.7 in Q3 2024, and up 807.97% quarter-over-quarter from $18042.0 in Q1 2025.
Ping An Biomedical (PASW) Cash & Equivalents (2024 - 2025) Analysis & Trends
Ping An Biomedical has reported Cash & Equivalents for 2 years, with the latest figure at $163816.4 in Q3 2025.
- For the quarter ending Q3 2025, Cash & Equivalents rose 796.76% year-over-year to $163816.4; the trailing twelve-month figure through Sep 2025 stood at $163816.4 (up 796.76% YoY), and the FY2025 full-year result was $164697.0, up 801.58% from the prior year.
- Cash & Equivalents for Q3 2025 stood at $163816.4, up from $18042.0 in the prior quarter.
- The five-year high for Cash & Equivalents was $163816.4 in Q3 2025, with the low at $18042.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Albany International | 1.99 Bn | 1.87 Bn | 99.79 Mn | 122.56 Mn |
| 2 | Unifi | 73.82 Mn | 45.35 Mn | 9.12 Mn | 26.56 Mn |
| 3 | Ping An Biomedical | 427,306.12 | -4.70 Mn | - | 163,816.43 |
| 4 | Culp | - | - | 5.32 Mn | 9.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 163,816.43 |
| Mar 31, 2025 | 18,042.00 |
| Sep 30, 2024 | 18,267.66 |
| Mar 31, 2024 | 82,771.36 |